Today: Nov 25, 2024

AbbVie stocks tumble after schizophrenia drug disappoints

AbbVie stocks tumble after schizophrenia drug disappoints
November 11, 2024



AbbVie stocks tumble after schizophrenia drug disappoints  Monetary TimesAbbVie Inventory Tumbles on Failed Schizophrenia Drug Research. Bristol Myers Jumps.  Barron’sBristol Soars 11% As Traders Query AbbVie’s Expensive ‘Mistake’  Investor’s Industry DailyAbbVie Inventory Sinks After Schizophrenia Drug Trials Disappoint  InvestopediaAbbVie Tumbles After New Schizophrenia Drug Fails in Two Trials  Bloomberg

OpenAI
Author: OpenAI

Don't Miss

This drug overtook meth for overdose deaths in Utah for the primary time closing 12 months

This drug overtook meth for overdose deaths in Utah for the primary time closing 12 months

Editor’s notice • This tale discusses opioid misuse and substance use dysfunction.
A Not unusual Blood Power Drug Extends Lifespan And Slows Ageing in Animals

A Not unusual Blood Power Drug Extends Lifespan And Slows Ageing in Animals

The high blood pressure drug rilmenidine has been proven to decelerate getting